NATCOPHARM.NSNATCOPHARM.NSNSE
Loading
Gross Profit Over TimeStrong
Percentile Rank100
3Y CAGR+22.1%
5Y CAGR+19.7%
Studio
Year-over-Year Change

Revenue minus cost of goods sold

3Y CAGR
+22.1%/yr
vs +4.6%/yr prior
5Y CAGR
+19.7%/yr
Consistent
Acceleration
+17.5pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.5x
Strong expansion
Streak
4 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$37.40B+1.0%
2025$37.05B+13.9%
2024$32.53B+58.4%
2023$20.54B+50.8%
2022$13.62B-10.7%
2021$15.24B+1.0%
2020$15.09B-11.9%
2019$17.13B-1.3%
2018$17.35B+24.6%
2017$13.92B-